# Gpc3 selectively suppresses subcutaneous adipogenesis in diet-induced obesity

**Authors:** Yan Li, Ming Tao, Carlos F. Ibáñez, Meng Xie, Lucas Smith, Lucas Smith, Lucas Smith, Lucas Smith, Lucas Smith

PMC · DOI: 10.1371/journal.pbio.3003700 · 2026-03-04

## TL;DR

This study identifies a gene, Gpc3, that controls how fat expands in different body regions during obesity.

## Contribution

The study discovers Gpc3 as a novel obesity-responsive gene that regulates depot-specific adipose expansion.

## Key findings

- ASPC-specific Gpc3 deletion in mice increases high-fat diet-induced weight and fat mass gain.
- Gpc3 loss biases adipose stem cell fate toward adipogenesis in inguinal white adipose tissue.
- Gpc3 modulates adipose expansion through depot-specific effects on Wnt signaling.

## Abstract

Subcutaneous and visceral adipose depots employ distinct expansion strategies in response to dietary cues, yet the molecular regulators underlying these depot-specific adaptations remain poorly understood. Through integrated proteomic profiling of human subcutaneous and visceral adipose tissues from paired obese/non-obese donors and temporal transcriptomic analysis of mouse adipose stem and progenitor cells (ASPCs) during dietary transitions, we identified Glypican 3 (Gpc3) as an obesity-responsive gene exhibiting reciprocal expression patterns between depots. ASPC-specific Gpc3 deletion in mice amplified high-fat diet-induced weight and fat mass gain, with a selective enhancement of expansion in inguinal white adipose tissue (WAT) without affecting epididymal WAT. Mechanistically, Gpc3 loss biased ASPC fate toward adipogenesis over proliferation through depot-specific modulation of canonical Wnt signaling. These findings establish Gpc3 as a regulator for regional adipose plasticity, offering a molecular target for reprogramming pathological fat distribution in obesity and related metabolic disorders.

Why does fat expand differently in distinct body regions? This study identifies Gpc3 as regional depot-specific obesity responsive gene that selectively promotes the expansion of inguinal, but not epididymal, white adipose tissue in mice fed a high fat diet.

## Linked entities

- **Genes:** GPC3 (glypican 3) [NCBI Gene 2719]
- **Diseases:** obesity (MONDO:0011122)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Ccnd1 (cyclin D1) [NCBI Gene 12443] {aka CycD1, Cyl-1, PRAD1, bcl-1, cD1}, Blnk (B cell linker) [NCBI Gene 17060] {aka BASH, Bca, Ly-57, Ly57, Lyw-57, SLP-65}, Icam1 (intercellular adhesion molecule 1) [NCBI Gene 15894] {aka CD54, Icam-1, Ly-47, MALA-2}, Dgat2 (diacylglycerol O-acyltransferase 2) [NCBI Gene 67800] {aka 0610010B06Rik, ARAT, DGAT-2}, LRP5 (LDL receptor related protein 5) [NCBI Gene 4041] {aka BMND1, EVR1, EVR4, HBM, LR3, LRP-5}, Apc (APC, WNT signaling pathway regulator) [NCBI Gene 11789] {aka CC1, Min, mAPC}, Aspscr1 (ASPSCR1 tether for SLC2A4, UBX domain containing) [NCBI Gene 68938] {aka 1190006K01Rik, ASPC, ASPCR1, ASPL, ASPS, RCC17}, Wnt3a (wingless-type MMTV integration site family, member 3A) [NCBI Gene 22416] {aka Wnt-3a, vt}, Pparg (peroxisome proliferator activated receptor gamma) [NCBI Gene 19016] {aka Nr1c3, PPAR-gamma, PPAR-gamma2, PPARgamma, PPARgamma2}, CEBPA (CCAAT enhancer binding protein alpha) [NCBI Gene 1050] {aka C/EBP-alpha, CEBP}, Gsk3b (glycogen synthase kinase 3 beta) [NCBI Gene 56637] {aka 7330414F15Rik, 8430431H08Rik, GSK-3, GSK-3beta, GSK3}, Camk2a (calcium/calmodulin-dependent protein kinase II alpha) [NCBI Gene 12322] {aka CaMKII, mKIAA0968}, Axin1 (axin 1) [NCBI Gene 12005] {aka Axin, Fu, Kb, Ki, fused, kinky}, Pdgfra (platelet derived growth factor receptor, alpha polypeptide) [NCBI Gene 18595] {aka CD140a, Pdgfr-2}, Gpc3 (glypican 3) [NCBI Gene 14734] {aka OCI-5}, ABCB7 (ATP binding cassette subfamily B member 7) [NCBI Gene 22] {aka ABC7, ASAT, Atm1p, EST140535}, Dpp4 (dipeptidylpeptidase 4) [NCBI Gene 13482] {aka Cd26, Dpp-4, THAM}, Ctnnb1 (catenin beta 1) [NCBI Gene 12387] {aka Bfc, Catnb, Mesc}, Cort (cortistatin) [NCBI Gene 12854] {aka CST, PCST}, Pi16 (peptidase inhibitor 16) [NCBI Gene 74116] {aka 1200009H11Rik, Cripi, PI-16}, Mir717 (microRNA 717) [NCBI Gene 751531] {aka Mirn717, mir-717, mmu-mir-717}, Pdgfrb (platelet derived growth factor receptor, beta polypeptide) [NCBI Gene 18596] {aka CD140b, PDGFR-1, Pdgfr}, GPC3 (glypican 3) [NCBI Gene 2719] {aka DGSX, GTR2-2, MXR7, OCI-5, SDYS, SGB}, Cebpa (CCAAT/enhancer binding protein alpha) [NCBI Gene 12606] {aka C/ebpalpha, CBF-A, Cebp}, Fcgr3 (Fc receptor, IgG, low affinity III) [NCBI Gene 14131] {aka CD16}, Fcgr2b (Fc receptor, IgG, low affinity IIb) [NCBI Gene 14130] {aka CD32, F630109E10Rik, Fc[g]RII, FcgRII, Fcgr2, Fcgr2a}, PPARG (peroxisome proliferator activated receptor gamma) [NCBI Gene 5468] {aka CIMT1, FPLD3, GLM1, NR1C3, PPARG1, PPARG2}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}
- **Diseases:** tumor (MESH:D009369), fibrosis (MESH:D005355), inflammation (MESH:D007249), ASPCs (MESH:D000092423), fibro (MESH:D009810), IACUC (MESH:D000820), HFD (MESH:D004620), metabolic disease (MESH:D008659), Diet-Induced Obesity (MESH:D009765), weight gain (MESH:D015430), insulin resistance (MESH:D007333), hypertrophy (MESH:D006984), SVF (MESH:D054144), adipocyte hyperplasia (MESH:D006965), developmental delay (MESH:D002658), UMAP (MESH:C567162), hepatocellular carcinoma (MESH:D006528), heart failure (MESH:D006333), type 2 diabetes (MESH:D003924)
- **Chemicals:** streptomycin (MESH:D013307), acetonitrile (MESH:C032159), 7-AAD (MESH:C025942), nitrogen (MESH:D009584), F-12 (MESH:C007782), BrdU (MESH:D001973), NP-40 (MESH:C010615), tetramethylbenzidine (MESH:C021758), tamoxifen (MESH:D013629), DEPC (MESH:D004047), formic acid (MESH:C030544), P (MESH:D010758), trypan blue (MESH:D014343), NaCl (MESH:D012965), fat (MESH:D005223), MgCl2 (MESH:D015636), paraffin (MESH:D010232), Blood glucose (MESH:D001786), ethanol (MESH:D000431), GlutaMAX (MESH:C054122), SDS (MESH:D012967), isopropanol (MESH:D019840), HCl (MESH:D006851), d-biotin (MESH:D001710), CaCl2 (MESH:D002122), DTT (MESH:D004229), iodoacetamide (MESH:D007460), TRIzol (MESH:C411644), Oil Red O (MESH:C011049), CHIR99021 (MESH:C473711), water (MESH:D014867), acetone (MESH:D000096), urea (MESH:D014508), XAV939 (MESH:C544261), IBMX (MESH:D015056), dexamethasone (MESH:D003907), corn oil (MESH:D003314), rosiglitazone (MESH:D000077154), Na (MESH:D012964), penicillin (MESH:D010406), HEPES (MESH:D006531), S (MESH:D013455), H&amp;E (MESH:D006371), DIA (-), guanidine hydrochloride (MESH:D019791), reactive oxygen species (MESH:D017382), D-glucose (MESH:D005947), DAPI (MESH:C007293), DMSO (MESH:D004121), T3 (MESH:D014284), PVDF (MESH:C024865), KCl (MESH:D011189), Tween-20 (MESH:D011136), PBS (MESH:D007854), agarose (MESH:D012685), sucrose (MESH:D013395), lipid (MESH:D008055), cysteine (MESH:D003545), PFA (MESH:C003043), triethylammonium bicarbonate (MESH:C041737)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116]
- **Cell lines:** SVF — Mus musculus (Mouse), Transformed cell line (CVCL_ZD83), /6J — Homo sapiens (Human), Cutaneous melanoma, Cancer cell line (CVCL_W797)

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12978566/full.md

---
Source: https://tomesphere.com/paper/PMC12978566